Our team presented at the International Papillomavirus Conference 2023 held in Washington DC, April 17-22, 2023:
- Jean-François Laprise made an oral presentation on the “Potential impact of switching from a 2-dose to 1-dose routine HPV vaccination program in high-income countries: A mathematical modeling study using North America as an example”.
- Élodie Bénard made a poster presentation on the “Potential impact of one-dose HPV vaccination in low-and middle-income countries: a modelling analysis”.
